The Food and Drug Administration told Merck & amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to defunct pain reliever the pharmaceutical maker announced Friday.
Shares of Merck & amp; Co. plunged more than 10 percent Monday after documents show the pharmaceutical giant hid or denied evidence that its blockbuster arthritis drug cause heart problems.
The two Merck & amp; Co. executives were somber as the company plane pitched and rolled through the remnants of Hurricane Jeanne.
